Market Update (NYSE:LLY): Zosano Pharma and Eli Lilly and Company Enter Into Exclusive Licensing Agreement for Zosano’s ZP-PTH Product Candidate

[GlobeNewswire] – FREMONT, Calif. and INDIANAPOLIS — Zosano Pharma Corporation (Zosano) and Eli Lilly and Company today announced that they have entered into an exclusive agreement to develop ZP-PTH, Zosano’s proprietary … Read . . . → Read More: Market Update (NYSE:LLY): Zosano Pharma and Eli Lilly and Company Enter Into Exclusive Licensing Agreement for Zosano’s ZP-PTH Product Candidate Similar Articles: Company Update (NYSE:LLY): Lilly Declares Fourth-Quarter 2014 Dividend Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference Eli Lilly & Company (NYSE:LLY) | Lilly for Better Health™ expands website’s non-product-branded health education resources, focuses on healthy behavior skills